GH1 and prediabetes syndrome: Underlying pathophysiological mechanisms for the hyperinsulinemia, insulin resistance, and prediabetes/diabetes in active acromegaly, are GH-mediated increased lipolysis, reduced peripheral glucose utilization, and enhanced gluconeogenesis by the insulin-antagonizing effects of GH [90,91].